Skip to content
healthcare.dev

Deferasirox

NDC 72205-389, Deferasirox, tablet, for suspension, from Novadoz Pharmaceuticals LLC.

Product NDC
72205-389
Status
Listed
Labeler
Novadoz Pharmaceuticals LLC
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209878
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72205-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX125 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
72205-389-017220503890130 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-01)
72205-389-027220503890290 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-02)
72205-389-03722050389031000 TABLET, FOR SUSPENSION in 1 BOTTLE (72205-389-03)
72205-389-057220503890510 BLISTER PACK in 1 CARTON (72205-389-05) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a03c7657-fdca-4acb-ad82-c24680e90eae

Use it

Look up 72205-389 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72205-389 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72205-389. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.